Merdad V. Parsey
2020
In 2020, Merdad V. Parsey earned a total compensation of $7.2M as Chief Medical Officer at Gilead Sciences, a 130% increase compared to previous year.
Compensation breakdown
| Bonus | $1,000,000 |
|---|---|
| Non-Equity Incentive Plan | $1,794,000 |
| Option Awards | $1,000,033 |
| Salary | $1,038,462 |
| Stock Awards | $2,332,860 |
| Other | $15,000 |
| Total | $7,180,355 |
Parsey received $2.3M in stock awards, accounting for 32% of the total pay in 2020.
Parsey also received $1M in bonus, $1.8M in non-equity incentive plan, $1M in option awards, $1M in salary and $15K in other compensation.
Rankings
In 2020, Merdad V. Parsey's compensation ranked 1,350th out of 13,090 executives tracked by ExecPay. In other words, Parsey earned more than 89.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,350 out of 13,090 | 90th |
Division Manufacturing | 491 out of 5,617 | 91st |
Major group Chemicals And Allied Products | 172 out of 2,248 | 92nd |
Industry group Drugs | 147 out of 1,948 | 93rd |
Industry Biological Products, Except Diagnostic Substances | 42 out of 411 | 90th |
Pay ratio
| Merdad V. Parsey's Pay | $7,180,355 |
|---|---|
| Median Employee's Pay | $250,190 |
| Pay Ratio | 29to 1 |
In 2020, the annual total compensation of Merdad V. Parsey was $7,180,355.
The annual total compensation of the median employee at Gilead Sciences was $250,190.
The ratio of Merdad V. Parsey's pay to the pay of median employee was therefore 29 to one.
Source: SEC filing on March 30, 2021.
Parsey's colleagues
We found four more compensation records of executives who worked with Merdad V. Parsey at Gilead Sciences in 2020.